Centers

UCSC Chemical Screening Center

Saint Louis University Institute for Drug and Biotherapeutic Innovation (IDBI)

Edinburgh Drug Discovery

We are a shared research facility dedicated to improving human health by finding therapeutic agents against a wide variety of diseases, dedicated to advancing scientific knowledge and technologies, and dedicated to education of the next generation of...

Read more

 

The IDBI is a decentralized, collaborative institute whose mission is to promote the translation of research projects at Saint Louis University through drug discovery and pre-clinical development. The IDBI achieves this through four main...

Read more

Based within the world-leading University of Edinburgh Medical School, Edinburgh Drug Discovery has a track record in successfully translating drug discovery projects from target identification through to clinical evaluation. Key areas of...

Read more

Partnerships

Events

Jobs

TB Drug Accelerator

  • The TB Drug Accelerator Programme aims to speed up the discovery and development of novel compounds against tuberculosis (TB).

 
View all

Sanofi and Stanford's Bio-X to Collaborate on Early Stage Research

Sanofi and Stanford University's Bio-X have entered into a multi-year collaboration that support interdisciplinary collaborative research to be conducted at Stanford. A joint steering committee comprising of representatives from Stanford and...

 
View all

GSK and MD Anderson to co-develop new cancer therapeutics

GlaxoSmithkline and MD Anderson Cancer Center entered into a co-development and license agreement to develop antibody based therapeutics to treat cancer. Under this agreement MD Anderson grants exclusive rights to antibodies developed during the...

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All